E²CM - E²CM²

Crossborder co-development of
4D Engineered ECM technology
for regenerative therapies.
The E²CM project carries out research
in the field of regenerative medicine
and is supported by CrossRoads2.
E²CM partners ReGenesys,
IME Technologies and Antleron
target cells and biomaterials to be transformed via electrospinning, 3D printing and bioreactors into a tissue engineered product

More information about the E²CM project:

IME Technologies

ReGenesys

Contact Us 

Mon18Dec2017193041GMTantleronBio_Incubat

Gaston Geenslaan 1

3001 Leuven, Belgium

Sun17Dec2017212239GMTantleronbiohublogo_

Ambachtenlaan 1

3001 Leuven, Belgium

Subscribe to get our newsletter

Tel +32 (0)16 75 13 71

Email info@antleron.com

VAT BE 0505.975.160

Our core partners:

qbd_logo.png
3D_Systems_Logo (1).png

© 2019 by Websters